MedTrace Logo

VIDAS® NEPHROCLEAR Diagnostic Accuracy Study

NCT06036758 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 477

Last updated 2024-02-28

No results posted yet for this study

Summary

This is a multi-center sample analysis study in which urine samples previously collected from persons with Stage 2 or Stage 3 Acute Kidney Injury (AKI), will be tested in order to validate the VIDAS® NEPHROCLEAR™ CCL14 Test

Conditions

Interventions

DIAGNOSTIC_TEST

VIDAS® NEPHROCLEAR™ CCL14 Test

Urine samples previously collected from persons with stage 2/stage 3 AKI will be tested using the VIDAS® NEPHROCLEAR™ CCL14 Test

Sponsors & Collaborators

  • BioMérieux

    lead INDUSTRY

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-17
Primary Completion
2023-12-28
Completion
2023-12-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06036758 on ClinicalTrials.gov